4//SEC Filing
McGovern Jr. Donald A. 4
Accession 0001213900-23-074482
CIK 0001690080other
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 6:28 PM ET
Size
10.4 KB
Accession
0001213900-23-074482
Insider Transaction Report
Form 4
McGovern Jr. Donald A.
Director
Transactions
- Award
Common Stock
2023-09-04+25,186→ 55,285 total - Award
Non-Qualified Stock Option (right to buy)
2023-09-04+44,776→ 44,776 totalExercise: $0.67From: 2023-09-04Exp: 2033-09-04→ Common Stock (44,776 underlying) - Award
Non-Qualified Stock Option (right to buy)
2023-09-04+15,000→ 15,000 totalExercise: $0.67Exp: 2033-09-04→ Common Stock (15,000 underlying)
Footnotes (4)
- [F1]Issued in consideration for serving on the Board of Directors, as Lead Director, Chairman of the Audit Committee, and as a Member of the Compensation Committee and of the Risk, Safety and Regulatory Committee of the Board of Directors, for the quarter ended June 30, 2023. Granted under the registrant's First Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.
- [F2]Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's First Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.
- [F3]The options vest at the rate of 1/12th of such options ratably on a monthly basis over the following 12 months on the last day of each calendar month (beginning September 30, 2023), subject to the Reporting Person's continued service to the Company on such vesting dates.
- [F4]Granted in consideration for serving as Lead Director of the Company during 2023. Granted under the registrant's First Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.
Documents
Issuer
180 Life Sciences Corp.
CIK 0001690080
Entity typeother
Related Parties
1- filerCIK 0001706276
Filing Metadata
- Form type
- 4
- Filed
- Sep 5, 8:00 PM ET
- Accepted
- Sep 6, 6:28 PM ET
- Size
- 10.4 KB